Aclarion - Crunchbase Company Profile & Funding

Q: Where is Aclarion's headquarters?

Aclarion is located in Broomfield, Colorado, United States.

Q: Who invested in Aclarion?

Aclarion is funded by TCA Venture Group.

Q: When was the last funding round for Aclarion?

Aclarion closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Aclarion raised to date?

Aclarion has raised obfuscated.

Overview

Aclarion

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Aclarion

CB Rank

3904

Aclarion is a healthcare technology company that assists with medical imaging and diagnosis.

Founded

obfuscation

Public

Post-IPO Equity

Broomfield, Colorado, United States

11-50

aclarion.com

Health Care

Medical

Medical Device

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Key People

James Abel: VP of Software Engineering
Gregory Gould: Chief Financial Officer
Past Role: Charlotte's Web, Chief Financial Officer and Chief Administration Officer

Details

Legal Name

ACLARION, INC.

Also Known As

NociMed

Operating Status

Active

Stock Symbol

NASDAQ:ACON

Company Type

For Profit

Founders

David Bradford, Jeff Lotz, Jim Peacock

About the Company

Aclarion is a healthcare technology company that assists with medical imaging and diagnosis using a SaaS-based radiology image analysis tool. It is a signal-processing software that converts raw data into clear metabolic biomarkers to optimize clinical treatments.

Phone Number

833-275-2266

Contact Email

info@nocimed.com

Predictions & Insights

Growth Insight

See this Growth Insight

Aclarion is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

NOCISCAN

A SaaS platform utilizing MR Spectroscopy to help physicians noninvasively distinguish between painful and nonpainful discs in the spine, providing critical pain biomarker data.

Nociscan

Aclarion’s SaaS imaging platform that analyzes lumbar disc biomarkers via MRS data to help identify painful spinal discs.

Research & Development

Aclarion is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Aclarion	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
TCA Venture Group	—	Venture Round - Aclarion	—
TCA Venture Group	—	Venture Round - Aclarion	—
TCA Venture Group	—	Venture Round - Aclarion	—
TCA Venture Group	—	Venture Round - Aclarion	—
TCA Venture Group	—	Venture Round - Aclarion	—